US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist

68.050
+1.010+1.51%

Close Dec 3 16:00 ET

68.600
+0.550+0.81%

Post 20:01 ET

211.00BMarket Cap32.80P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

Net income from continuing operations

10.65%1.83B

14.80%2.4B

23.78%2.8B

175.85%6.9B

15.30%897M

78.98%1.65B

745.34%2.09B

309.04%2.26B

1,043.77%2.5B

222.33%778M

Other non cash items

220.23%839M

73.76%702M

-150.70%-356M

127.07%1.45B

142.04%927M

58.79%262M

308.08%404M

-1,675.00%-142M

-52.38%639M

-49.41%383M

Change In working capital

-95.43%41M

86.96%-129M

-288.02%-455M

-92.01%300M

-49.83%150M

-15.93%897M

-268.48%-989M

-86.59%242M

85.90%3.76B

811.90%299M

-Change in receivables

----

-5.63%-1.43B

----

-40.37%-1.35B

----

-Change in inventory

----

-116.98%-669M

----

149.90%3.94B

----

Cash from discontinued investing activities

Operating cash flow

8.64%3.38B

79.57%3.09B

-20.65%2.49B

5.48%10.35B

-0.75%2.38B

6.28%3.11B

37.66%1.72B

-3.06%3.13B

64.48%9.81B

69.11%2.4B

Investing cash flow

Cash flow from continuing investing activities

Net PPE purchase and sale

-32.80%-417M

-42.01%-382M

-198.36%-364M

-51.92%-1.23B

-389.72%-524M

-36.52%-314M

-6.32%-269M

44.29%-122M

24.95%-809M

66.56%-107M

Net intangibles purchase and sale

-62.32%-909M

-51.32%-286M

-16.06%-1.11B

-105.81%-2.13B

-136.16%-418M

35.19%-560M

18.88%-189M

-497.93%-959M

-97.89%-1.03B

54.85%-177M

Net business purchase and sale

-2.93%-281M

-1,221.74%-2.43B

-120.66%-940M

-11.12%-1.18B

-56.61%-296M

20.18%-273M

36.11%-184M

-76.03%-426M

88.75%-1.06B

13.30%-189M

Net investment purchase and sale

111.04%18M

109.09%115M

-568.42%-89M

94.02%-7M

-56.84%82M

49.54%-163M

266.67%55M

-61.22%19M

-48.10%-117M

2,211.11%190M

Net other investing changes

----

--190M

--0

--15M

--0

--175M

----

Cash from discontinued investing activities

Investing cash flow

-24.00%-1.51B

-452.31%-2.87B

-93.66%-2.41B

-37.30%-4.06B

-332.53%-1.08B

29.95%-1.22B

35.00%-520M

-641.67%-1.25B

73.23%-2.96B

72.73%-249M

Financing cash flow

Cash flow from continuing financing activities

Net issuance payments of debt

-100.08%-2.42B

21.20%-1.13B

211.10%5.97B

19.38%-965M

24.84%-236M

-2,184.48%-1.21B

-16.24%-1.44B

546.13%1.92B

-115.16%-1.2B

63.19%-314M

Net common stock issuance

-2,025.00%-77M

25.00%5M

50.00%6M

13.79%33M

16.67%21M

33.33%4M

-20.00%4M

0.00%29M

-5.26%18M

Cash dividends paid

-11.77%-1.58B

22.73%-17M

0.46%-3.03B

-2.68%-4.48B

---2M

-1.22%-1.41B

---22M

-2.56%-3.05B

-13.17%-4.36B

--0

Net other financing activities

152.17%24M

--0

-0.12%-841M

15.38%-886M

--0

8.00%-46M

--0

15.75%-840M

-488.20%-1.05B

--0

Cash from discontinued financing activities

Financing cash flow

-51.54%-4.13B

19.55%-1.22B

199.85%2.03B

3.75%-6.57B

18.72%-291M

-90.63%-2.73B

-17.30%-1.52B

45.70%-2.03B

-286.98%-6.82B

65.94%-358M

Net cash flow

Beginning cash position

22.04%6.68B

31.98%7.69B

-5.78%5.64B

-0.91%5.98B

10.34%4.62B

22.12%5.47B

8.87%5.83B

-0.91%5.98B

-19.98%6.04B

-36.32%4.19B

Current changes in cash

-171.55%-2.26B

-214.33%-1.01B

1,559.03%2.1B

-1,244.00%-286M

-43.50%1.01B

-242.80%-833M

62.10%-321M

78.70%-144M

101.73%25M

428.02%1.79B

Effect of exchange rate changes

205.26%20M

83.33%-6M

-318.18%-46M

25.00%-60M

0.00%6M

62.75%-19M

-38.46%-36M

-22.22%-11M

-29.03%-80M

-45.45%6M

End cash Position

-3.98%4.44B

22.04%6.68B

31.98%7.69B

-5.78%5.64B

10.34%4.62B

22.12%5.47B

8.87%5.83B

-0.91%5.98B

Free cash flow

-9.40%2.03B

95.71%2.42B

-47.02%881M

-9.26%6.57B

-22.23%1.43B

22.87%2.24B

75.18%1.24B

-42.04%1.66B

92.32%7.24B

163.43%1.84B

Currency Unit

USD

Accounting Standards

NonUS-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations	10.65%1.83B	14.80%2.4B	23.78%2.8B	175.85%6.9B	15.30%897M	78.98%1.65B	745.34%2.09B	309.04%2.26B	1,043.77%2.5B	222.33%778M
Other non cash items	220.23%839M	73.76%702M	-150.70%-356M	127.07%1.45B	142.04%927M	58.79%262M	308.08%404M	-1,675.00%-142M	-52.38%639M	-49.41%383M
Change In working capital	-95.43%41M	86.96%-129M	-288.02%-455M	-92.01%300M	-49.83%150M	-15.93%897M	-268.48%-989M	-86.59%242M	85.90%3.76B	811.90%299M
-Change in receivables	----	----	----	-5.63%-1.43B	----	----	----	----	-40.37%-1.35B	----
-Change in inventory	----	----	----	-116.98%-669M	----	----	----	----	149.90%3.94B	----
Cash from discontinued investing activities
Operating cash flow	8.64%3.38B	79.57%3.09B	-20.65%2.49B	5.48%10.35B	-0.75%2.38B	6.28%3.11B	37.66%1.72B	-3.06%3.13B	64.48%9.81B	69.11%2.4B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale	-32.80%-417M	-42.01%-382M	-198.36%-364M	-51.92%-1.23B	-389.72%-524M	-36.52%-314M	-6.32%-269M	44.29%-122M	24.95%-809M	66.56%-107M
Net intangibles purchase and sale	-62.32%-909M	-51.32%-286M	-16.06%-1.11B	-105.81%-2.13B	-136.16%-418M	35.19%-560M	18.88%-189M	-497.93%-959M	-97.89%-1.03B	54.85%-177M
Net business purchase and sale	-2.93%-281M	-1,221.74%-2.43B	-120.66%-940M	-11.12%-1.18B	-56.61%-296M	20.18%-273M	36.11%-184M	-76.03%-426M	88.75%-1.06B	13.30%-189M
Net investment purchase and sale	111.04%18M	109.09%115M	-568.42%-89M	94.02%-7M	-56.84%82M	49.54%-163M	266.67%55M	-61.22%19M	-48.10%-117M	2,211.11%190M
Net other investing changes	----	----	----	--190M	--0	--15M	--0	--175M	----	----
Cash from discontinued investing activities
Investing cash flow	-24.00%-1.51B	-452.31%-2.87B	-93.66%-2.41B	-37.30%-4.06B	-332.53%-1.08B	29.95%-1.22B	35.00%-520M	-641.67%-1.25B	73.23%-2.96B	72.73%-249M
Financing cash flow
Cash flow from continuing financing activities
Net issuance payments of debt	-100.08%-2.42B	21.20%-1.13B	211.10%5.97B	19.38%-965M	24.84%-236M	-2,184.48%-1.21B	-16.24%-1.44B	546.13%1.92B	-115.16%-1.2B	63.19%-314M
Net common stock issuance	-2,025.00%-77M	25.00%5M	50.00%6M	13.79%33M	16.67%21M	33.33%4M	33.33%4M	-20.00%4M	0.00%29M	-5.26%18M
Cash dividends paid	-11.77%-1.58B	22.73%-17M	0.46%-3.03B	-2.68%-4.48B	---2M	-1.22%-1.41B	---22M	-2.56%-3.05B	-13.17%-4.36B	--0
Net other financing activities	152.17%24M	--0	-0.12%-841M	15.38%-886M	--0	8.00%-46M	--0	15.75%-840M	-488.20%-1.05B	--0
Cash from discontinued financing activities
Financing cash flow	-51.54%-4.13B	19.55%-1.22B	199.85%2.03B	3.75%-6.57B	18.72%-291M	-90.63%-2.73B	-17.30%-1.52B	45.70%-2.03B	-286.98%-6.82B	65.94%-358M
Net cash flow
Beginning cash position	22.04%6.68B	31.98%7.69B	-5.78%5.64B	-0.91%5.98B	10.34%4.62B	22.12%5.47B	8.87%5.83B	-0.91%5.98B	-19.98%6.04B	-36.32%4.19B
Current changes in cash	-171.55%-2.26B	-214.33%-1.01B	1,559.03%2.1B	-1,244.00%-286M	-43.50%1.01B	-242.80%-833M	62.10%-321M	78.70%-144M	101.73%25M	428.02%1.79B
Effect of exchange rate changes	205.26%20M	83.33%-6M	-318.18%-46M	25.00%-60M	0.00%6M	62.75%-19M	-38.46%-36M	-22.22%-11M	-29.03%-80M	-45.45%6M
End cash Position	-3.98%4.44B	22.04%6.68B	31.98%7.69B	-5.78%5.64B	-5.78%5.64B	10.34%4.62B	22.12%5.47B	8.87%5.83B	-0.91%5.98B	-0.91%5.98B
Free cash flow	-9.40%2.03B	95.71%2.42B	-47.02%881M	-9.26%6.57B	-22.23%1.43B	22.87%2.24B	75.18%1.24B	-42.04%1.66B	92.32%7.24B	163.43%1.84B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Heat List

Overall

No Data

Investment Theme

Infectious Disease

Intraday-0.12%